STEMLINE THERAPEUTICS INC's ticker is STML and the CUSIP is 85858C107. A total of 74 filers reported holding STEMLINE THERAPEUTICS INC in Q4 2016. The put-call ratio across all filers is 1.21 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $74,000 | +221.7% | 7,115 | +364.4% | 0.01% | +150.0% |
| Q2 2019 | $23,000 | +228.6% | 1,532 | +245.0% | 0.00% | +100.0% |
| Q3 2018 | $7,000 | -78.1% | 444 | -77.8% | 0.00% | -50.0% |
| Q2 2018 | $32,000 | +255.6% | 2,002 | +242.8% | 0.00% | +100.0% |
| Q4 2017 | $9,000 | -72.7% | 584 | -79.9% | 0.00% | -66.7% |
| Q3 2017 | $33,000 | +3200.0% | 2,909 | +4055.7% | 0.00% | – |
| Q2 2017 | $1,000 | -93.3% | 70 | -96.0% | 0.00% | -100.0% |
| Q1 2017 | $15,000 | +200.0% | 1,751 | +283.2% | 0.00% | 0.0% |
| Q4 2016 | $5,000 | -28.6% | 457 | -55.0% | 0.00% | 0.0% |
| Q2 2016 | $7,000 | -70.8% | 1,015 | -80.5% | 0.00% | -75.0% |
| Q1 2016 | $24,000 | +26.3% | 5,207 | +77.0% | 0.00% | +33.3% |
| Q4 2015 | $19,000 | -24.0% | 2,942 | +4.1% | 0.00% | +50.0% |
| Q3 2015 | $25,000 | +212.5% | 2,825 | +328.0% | 0.00% | +100.0% |
| Q2 2015 | $8,000 | -60.0% | 660 | -53.0% | 0.00% | -50.0% |
| Q1 2015 | $20,000 | 0.0% | 1,403 | +20.5% | 0.00% | 0.0% |
| Q4 2014 | $20,000 | -41.2% | 1,164 | -57.6% | 0.00% | -50.0% |
| Q3 2014 | $34,000 | 0.0% | 2,748 | +18.2% | 0.00% | 0.0% |
| Q2 2014 | $34,000 | +17.2% | 2,324 | +58.1% | 0.00% | -20.0% |
| Q4 2013 | $29,000 | +141.7% | 1,470 | +212.8% | 0.01% | +400.0% |
| Q2 2013 | $12,000 | – | 470 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|